MIFH
Migdal Insurance & Financial Holdings Portfolio holdings
AUM
$8.42B
1-Year Return
18.65%
This Quarter Return
+9.91%
1 Year Return
+18.65%
3 Year Return
+96.52%
5 Year Return
+186.2%
10 Year Return
–
AUM
$9.54B
AUM Growth
-$384M
(-3.9%)
Cap. Flow
-$1.06B
Cap. Flow
% of AUM
-11.15%
Top 10 Holdings %
Top 10 Hldgs %
34.97%
Holding
704
New
37
Increased
192
Reduced
239
Closed
122
Top Buys
| 1 |
Apple
AAPL
|
+$75.5M |
| 2 |
iShares MSCI Brazil ETF
EWZ
|
+$68.8M |
| 3 |
Pfizer
PFE
|
+$66.3M |
| 4 |
Tesla
TSLA
|
+$54.4M |
| 5 |
Health Care Select Sector SPDR Fund
XLV
|
+$47.7M |
Top Sells
| 1 |
SPDR S&P Bank ETF
KBE
|
+$332M |
| 2 |
Vanguard Russell 2000 ETF
VTWO
|
+$200M |
| 3 |
Industrial Select Sector SPDR Fund
XLI
|
+$166M |
| 4 |
Citigroup
C
|
+$88.2M |
| 5 |
Bank of America
BAC
|
+$83M |
Sector Composition
| 1 | Technology | 23.54% |
| 2 | Consumer Discretionary | 9.15% |
| 3 | Financials | 8.1% |
| 4 | Communication Services | 8.01% |
| 5 | Industrials | 7.63% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
626
iShares US Healthcare Providers ETF
IHF
$824M
| – | – |
-1,078,000
| Closed | -$54.3M |
|
627
Illumina
ILMN
$14.6B
| – | – |
-2,015
| Closed | -$753K |
|
628
Incyte
INCY
$16.2B
| – | – |
-440
| Closed | -$36K |
|
629
Inovio Pharmaceuticals
INO
$126M
| – | – |
-4,514
| Closed | -$503K |
|
630
Ionis Pharmaceuticals
IONS
$10.1B
| – | – |
-13,305
| Closed | -$598K |
|
631
Jacobs Solutions
J
$17.5B
| – | – |
-928
| Closed | -$99K |
|
632
Kroger
KR
$45.2B
| – | – |
-1,229
| Closed | -$44K |
|
633
Krystal Biotech
KRYS
$4.16B
| – | – |
-12,640
| Closed | -$974K |
|
634
Kohl's
KSS
$1.71B
| – | – |
-673,529
| Closed | -$40.1M |
|
635
Standard BioTools
LAB
$493M
| – | – |
-110,807
| Closed | -$501K |
|
636
Southwest Airlines
LUV
$16.6B
| – | – |
-550,000
| Closed | -$33.6M |
|
637
Mattel
MAT
$5.72B
| – | – |
-2,300,000
| Closed | -$45.8M |
|
638
Moody's
MCO
$91.9B
| – | – |
-441
| Closed | -$132K |
|
639
MeiraGTx Holdings
MGTX
$612M
| – | – |
-48,508
| Closed | -$700K |
|
640
Martin Marietta Materials
MLM
$37.1B
| – | – |
-146
| Closed | -$49K |
|
641
Moderna
MRNA
$9.15B
| – | – |
-4,312
| Closed | -$565K |
|
642
Myriad Genetics
MYGN
$674M
| – | – |
-36,322
| Closed | -$1.11M |
|
643
NeoGenomics
NEO
$1.03B
| – | – |
-14,154
| Closed | -$683K |
|
644
Nano X Imaging
NNOX
$249M
| – | – |
-120,000
| Closed | -$4.97M |
|
645
Intellia Therapeutics
NTLA
$1.23B
| – | – |
-15,800
| Closed | -$1.27M |
|
646
Natera
NTRA
$23.1B
| – | – |
-7,622
| Closed | -$774K |
|
647
Blue Owl Capital
OBDC
$7.23B
| – | – |
-606,796
| Closed | -$8.64M |
|
648
Pacific Biosciences
PACB
$351M
| – | – |
-35,786
| Closed | -$1.19M |
|
649
Passage Bio
PASG
$22.3M
| – | – |
-1,413
| Closed | -$494K |
|
650
Procter & Gamble
PG
$370B
| – | – |
-182
| Closed | -$25K |
|